Scholars Central

Conference abstract

Evaluation of rivastigmine efficacy in treatment of major depressive disorder: a randomized double blind controlled trial

Authors: Amir Mohammad Shabani, Samaneh Farnia, Naemeh Tabaraee, Seyed Davood hoseini, Narjes Hendouei

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background & Aim: Rivastigmine, a reversible inhibitor of acetylcholinesterase, which is used in treatment of mild to moderate AlzheimerâÂ?Â?s disease. In recent years, several studies have been conducted on the use of this drug in psychiatric disorders (e.g., dementia, Lewy body and autism), but few reports are exist associated with the use of rivastigmine in the treatment of depression in the absence of cognitive impairment. In this study, the aim was to determine whether adding rivastigmine to the standard therapeutic regimen of patients with major depression could improve some aspects of the symptom burden or not. Materials & Methods: Twenty patients with major depression were recruited randomly and then received either 3 milligram daily with sertraline regimen or with sertraline regimen only. Hamilton depression scale and Wechsler Memory were evaluated in patients at the baseline, end of first, second and third months. P values of less than 0.05 were considered significant. Results: During the study, the Hamilton Depression Scale score changes within groups were F (2/61, 47/1) = 35/8, p<0/001, Partial eta squared=0/66. But the changes of Hamilton Depression Scale scores werenâÂ?Â?t significant between groups (p value=0.2). The changes of Wechsler Memory Scale were 13Ã?±4.7 (95% CI=-9.616.3) and 8.07Ã?±4.9 (95%CI=-0.8-10.6) in rivastigmine and control group respectively (p=0.01) and there was a significant difference in first, third and Seventh Wechsler Memory Subscale scores (p=0.05, p=0.007, p<0.001 respectively). Conclusion: In this study, use of rivastigmine compared with placebo in MDD patients had significant effects on the reduction memory dysfunction, especially in personal information, orientation and auditory memory.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalQuality in Primary Care
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Amir Mohammad Shabani”
  • BylineArticles whose byline prints “Samaneh Farnia”
  • BylineArticles whose byline prints “Naemeh Tabaraee”
  • BylineArticles whose byline prints “Seyed Davood hoseini”
  • BylineArticles whose byline prints “Narjes Hendouei”